NACLC 2025

NACLC 2025

1. OncUpdates panel featuring leading oncologists discussing advances in EGFR-Mutant NSCLC treatment strategies.

NACLC 2025

12/30/2025

EP. 5: Closing Perspectives on Advancing Care in EGFR-Positive NSCLC

Joshua Sabari, MDDanny Nguyen, MDEdgardo Santos Castillero, MD, FACP, FASCOEric Singhi, MDAlexander Spira, MD, PhD, FACP, FASCO
Advances in managing toxicities in Mariposa including IRRs, VTEs, and rash with expert strategies by Dr. Joshua Sabari, Dr. Danny Nguyen, Dr. Alexander Spira, and Dr. Edgardo Santos, featured on OncUpdates.

NACLC 2025

12/29/2025

Ep. 4: Managing Toxicities in MARIPOSA: Mitigating Treatment-Related Adverse Events

Joshua Sabari, MDDanny Nguyen, MDEdgardo Santos Castillero, MD, FACP, FASCOEric Singhi, MDAlexander Spira, MD, PhD, FACP, FASCO
OncUpdates panel discussing clinical insights on escalation versus de-escalation in EGFR-positive NSCLC with doctors Joshua Sabari, Danny Nguyen, Alexander Spira, Edgardo Santos, and Eric Singhi.

NACLC 2025

12/27/2025

Ep. 3: Clinical Insights: Escalation vs De-escalation in EGFR-Positive NSCLC

Joshua Sabari, MDDanny Nguyen, MDEdgardo Santos Castillero, MD, FACP, FASCOEric Singhi, MDAlexander Spira, MD, PhD, FACP, FASCO
1. Expert panel on CNS activity and resistance discussing Amivantamab and Lazertinib for cancer treatment with Dr. Joshua Sabari, Dr. Edgardo Santos, Dr. Eric Singhi, and Dr. Alexander Spira.

NACLC 2025

12/21/2025

Ep. 2: CNS Control and Resistance: Panel Examines Amivantamab Plus Lazertinib

Joshua Sabari, MDDanny Nguyen, MDEdgardo Santos Castillero, MD, FACP, FASCOEric Singhi, MDAlexander Spira, MD, PhD, FACP, FASCO
EGFR-Mutant NSCLC survival updates featuring experts Dr. Danny Nguyen, Dr. Eric Singhi, Dr. Alexander Spira, Dr. Edgardo Santos, and Dr. Joshua Sabari discussing Mariposa & FLAURA2 studies.

NACLC 2025

12/19/2025

Ep. 1: Overall Survival Updates in EGFR-Positive NSCLC: MARIPOSA and FLAURA2

Joshua Sabari, MDDanny Nguyen, MDEdgardo Santos Castillero, MD, FACP, FASCOEric Singhi, MDAlexander Spira, MD, PhD, FACP, FASCO
EGFR+ NSCLC metastatic cancer research researchers Dr. Joshua Sabari Dr. Danny Nguyen Dr. Eric Singhi Dr. Alexander Spira Dr. Edgardo Santos oncology clinical insights oncology updates.

NACLC 2025

12/16/2025

Clinical Insights: Metastatic EGFR+ NSCLC from MARIPOSA and PALOMA-3

Joshua Sabari, MDAlexander Spira, MD, PhD, FACP, FASCODanny Nguyen, MDEdgardo Santos Castillero, MD, FACP, FASCOEric Singhi, MD